Chronic Pancreatitis Pain Market
Chronic pancreatitis is a long term inflammation of pancreas which leads to permanent damage and digestion capability of pancreas.
Chronic pancreatitis is a long term inflammation of pancreas which leads to permanent damage and digestion capability of pancreas.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Chronic</strong> <strong>Pancreatitis</strong> <strong>Pain</strong> <strong>Market</strong><br />
Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin<br />
America, and Middle East & Africa. Demand has been analyzed and forecast based on the<br />
current trends of the market. North America was the leading segment of chronic pancreatitis<br />
pain market followed by Europe in 2015 due to continuous increase in alcohol consumption. The<br />
chronic pancreatitis pain market is expected to witness the highest growth in the Asia-Pacific<br />
region mainly in China and India in the coming years due to the rising population, awareness as<br />
well as government initiative in these countries.<br />
Key players in chronic pancreatitis pain market include Abbott, Aptalis Pharma, Inc., McNeil<br />
Consumer Healthcare and Sun Biopharma.<br />
This report segments the chronic pancreatitis pain market are:-<br />
<strong>Chronic</strong> <strong>Pancreatitis</strong> <strong>Pain</strong> <strong>Market</strong>: Type Analysis<br />
<br />
<br />
Medicinal therapy<br />
Surgical therapy
Change language